Risk factors for haemorrhage in patients with haematological malignancies
<p>Haematological malignancies and their treatment lead to prolonged periods of severe thrombocytopenia (platelet count ≤ 50 x 10<sup>9</sup>/l). Despite the use of prophylactic platelet transfusions, haemorrhage remains an important complication during this thrombocytopenic period...
Main Author: | Estcourt, LJ |
---|---|
Other Authors: | Murphy, MF |
Format: | Thesis |
Language: | English |
Published: |
2014
|
Subjects: |
Similar Items
-
Loss of chaperone protein in human cancer
by: Adighibe, O
Published: (2012) -
Immunotherapy and immunomodulation for haematological malignancies
by: Mussai, F, et al.
Published: (2012) -
The role of Notch and GATA3 in postnatal and adult haematopoiesis
by: Duarte, S
Published: (2011) -
Investigating the specific roles of the growth factor kit ligand in the regulation of murine haematopoiesis
by: Facchini, RM
Published: (2015) -
The emergence and early fate decisions of stem and progenitor cells in the haematopoietic system
by: Lutteropp, M
Published: (2012)